Effect of Remimazolam on the Recovery Quality After Day Surgery
NCT ID: NCT05748665
Last Updated: 2024-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
118 participants
INTERVENTIONAL
2023-08-14
2024-01-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
• The quality of postoperative recovery induced by remimazolam for laryngeal mask general anesthesia in elderly patients undergoing day surgery is not inferior to that induced by etomidate Participants will be given remimazolam to induce anesthesia。 Researchers will compare etomidate to see if the quality of postoperative recovery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Median Effective Dose of Remimazolam for Sedation in Elderly Patients
NCT05468996
REmimazolam vs Propofol Total Intravenous Anesthesia on Outcomes After Major Noncardiac SurgEry
NCT05728775
Remimazolam and Endovascular Procedures of Cerebrovascular Diseases
NCT04950621
Comparison of Remimazolam and Propofol for Recovery of Ambulatory Upper Airway Surgery
NCT06507202
Clinical Studies of the Efficacy and Safety of Remimazolam for Anesthesia Induction and Maintenance in Elderly Patients
NCT06690424
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
remimazolam
remimazolam induction
Remimazolam besylate
Using remimazolam for induction of general anesthesia
etomidate
etomidate induction
etomidate
Using etomidate for induction of general anesthesia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Remimazolam besylate
Using remimazolam for induction of general anesthesia
etomidate
Using etomidate for induction of general anesthesia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American society of anesthesiologists (ASA) grade 1-3
* BMI\<30kg/m2
Exclusion Criteria
* Cognitive dysfunction and neuropsychiatric disorders
* It was estimated as a difficult airway
* There was a history of adrenal insufficiency, porphyria, or chronic corticosteroid therapy
* There is a contraindication or allergy to benzodiazepines, opioids, etomidate and its components
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xijing Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Fourth military medical university, Xijing Hospital
Xi'an, Shannxi, China
Xi 'an International Medical Center Hospital
Xi'an, Shannxi, China
Yan 'an University Affiliated Hospital
Yanan, Shannxi, China
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KY20222277-F-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.